Quart Barry D
CIK 0001384243
Chief Executive OfficerDirector
Filings
16
Latest Jun 2, 2026
Issuers covered
2
Showing
16 of 16
Page 1
Track record
11 of 11 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 11 | 45% | -1.2% | -2.4% | +7.0% | -17.5% |
| 90 days | 9 | 0% | -25.3% | -28.2% | -11.9% | -32.2% |
| 180 days | 3 | 0% | -38.0% | -37.5% | -37.0% | -39.6% |
| 365 days | - | - | - | - | - | - |
Issuers
Companies where Quart Barry D has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| KNSA | Kiniksa Pharmaceuticals, Ltd. | 12 | Jun 2, 2026 |
| HRTX | Heron Therapeutics, Inc. /De/ | 4 | Jan 20, 2023 |
All filings
16 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|